Di Monte DA - Search Results

1

Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD.

Woulfe JM, Duke R, Middeldorp JM, Stevens S, Vervoort M, Hashimoto M, Masliah E, Chan P, Di Monte DA, Langston JW, Petzinger G, Hoogendoorn H, Munoz DG. Woulfe JM, et al. Among authors: di monte da. Neurology. 2002 May 14;58(9):1435-6. doi: 10.1212/wnl.58.9.1435. Neurology. 2002. PMID: 12011302 Clinical Trial. No abstract available.

2

Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.

Chan P, Jiang X, Forno LS, Di Monte DA, Tanner CM, Langston JW. Chan P, et al. Among authors: di monte da. Neurology. 1998 Apr;50(4):1136-7. doi: 10.1212/wnl.50.4.1136. Neurology. 1998. PMID: 9566408

3

Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.

Langston JW, Sastry S, Chan P, Forno LS, Bolin LM, Di Monte DA. Langston JW, et al. Among authors: di monte da. Exp Neurol. 1998 Dec;154(2):684-90. doi: 10.1006/exnr.1998.6975. Exp Neurol. 1998. PMID: 9878203

4

Blood lactate in Parkinson's disease.

Di Monte D, Tetrud JW, Langston JW. Di Monte D, et al. Ann Neurol. 1991 Mar;29(3):342-3. doi: 10.1002/ana.410290323. Ann Neurol. 1991. PMID: 2042953 No abstract available.

5

Cerebrospinal fluid 3,4-dihydroxyphenylacetic acid level after tolcapone administration as an indicator of nigrostriatal degeneration.

Thiffault C, Langston JW, Di Monte DA. Thiffault C, et al. Among authors: di monte da. Exp Neurol. 2003 Sep;183(1):173-9. doi: 10.1016/s0014-4886(03)00140-7. Exp Neurol. 2003. PMID: 12957500

6

Decreased alpha-synuclein expression in the aging mouse substantia nigra.

Mak SK, McCormack AL, Langston JW, Kordower JH, Di Monte DA. Mak SK, et al. Among authors: di monte da. Exp Neurol. 2009 Dec;220(2):359-65. doi: 10.1016/j.expneurol.2009.09.021. Epub 2009 Oct 1. Exp Neurol. 2009. PMID: 19800328

7

CYP2D6 allelic frequencies in young-onset Parkinson's disease.

Sandy MS, Armstrong M, Tanner CM, Daly AK, Di Monte DA, Langston JW, Idle JR. Sandy MS, et al. Among authors: di monte da. Neurology. 1996 Jul;47(1):225-30. doi: 10.1212/wnl.47.1.225. Neurology. 1996. PMID: 8710083

8

Investigating levodopa-induced dyskinesias in the parkinsonian primate.

Langston JW, Quik M, Petzinger G, Jakowec M, Di Monte DA. Langston JW, et al. Among authors: di monte da. Ann Neurol. 2000 Apr;47(4 Suppl 1):S79-89. Ann Neurol. 2000. PMID: 10762135 Review.

9

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.

Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, Silverberg GD, Möller HJ, Yesavage JA, Tinklenberg JR, Shooter EM, Murphy GM Jr. Kahle PJ, et al. Among authors: di monte da. Neurology. 2000 Apr 11;54(7):1498-504. doi: 10.1212/wnl.54.7.1498. Neurology. 2000. PMID: 10751266 Clinical Trial.

10

The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.

Cox H, Togasaki DM, Chen L, Langston JW, Di Monte DA, Quik M. Cox H, et al. Among authors: di monte da. Exp Neurol. 2007 May;205(1):101-7. doi: 10.1016/j.expneurol.2007.01.024. Epub 2007 Feb 3. Exp Neurol. 2007. PMID: 17335811 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters